201 related articles for article (PubMed ID: 30977985)
1. Neurocan is a New Substrate for the ADAMTS12 Metalloprotease: Potential Implications in Neuropathies.
Fontanil T; Mohamedi Y; Moncada-Pazos A; Cobo T; Vega JA; Cobo JL; García-Suárez O; Cobo J; Obaya ÁJ; Cal S
Cell Physiol Biochem; 2019; 52(5):1003-1016. PubMed ID: 30977985
[TBL] [Abstract][Full Text] [Related]
2. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury.
Jones LL; Margolis RU; Tuszynski MH
Exp Neurol; 2003 Aug; 182(2):399-411. PubMed ID: 12895450
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican.
Milev P; Maurel P; Chiba A; Mevissen M; Popp S; Yamaguchi Y; Margolis RK; Margolis RU
Biochem Biophys Res Commun; 1998 Jun; 247(2):207-12. PubMed ID: 9642104
[TBL] [Abstract][Full Text] [Related]
4. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.
McKeon RJ; Jurynec MJ; Buck CR
J Neurosci; 1999 Dec; 19(24):10778-88. PubMed ID: 10594061
[TBL] [Abstract][Full Text] [Related]
5. New Insights into ADAMTS Metalloproteases in the Central Nervous System.
Mohamedi Y; Fontanil T; Cobo T; Cal S; Obaya AJ
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32150898
[TBL] [Abstract][Full Text] [Related]
6. Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue.
Grumet M; Milev P; Sakurai T; Karthikeyan L; Bourdon M; Margolis RK; Margolis RU
J Biol Chem; 1994 Apr; 269(16):12142-6. PubMed ID: 7512960
[TBL] [Abstract][Full Text] [Related]
7. Transient expression of juvenile-type neurocan by reactive astrocytes in adult rat brains injured by kainate-induced seizures as well as surgical incision.
Matsui F; Kawashima S; Shuo T; Yamauchi S; Tokita Y; Aono S; Keino H; Oohira A
Neuroscience; 2002; 112(4):773-81. PubMed ID: 12088737
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of nervous tissue: developmental changes of neurocan and phosphacan.
Meyer-Puttlitz B; Milev P; Junker E; Zimmer I; Margolis RU; Margolis RK
J Neurochem; 1995 Nov; 65(5):2327-37. PubMed ID: 7595522
[TBL] [Abstract][Full Text] [Related]
9. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth.
Friedlander DR; Milev P; Karthikeyan L; Margolis RK; Margolis RU; Grumet M
J Cell Biol; 1994 May; 125(3):669-80. PubMed ID: 7513709
[TBL] [Abstract][Full Text] [Related]
10. Human glioblastomas overexpress ADAMTS-5 that degrades brevican.
Nakada M; Miyamori H; Kita D; Takahashi T; Yamashita J; Sato H; Miura R; Yamaguchi Y; Okada Y
Acta Neuropathol; 2005 Sep; 110(3):239-46. PubMed ID: 16133547
[TBL] [Abstract][Full Text] [Related]
11. Hyalectanase Activities by the ADAMTS Metalloproteases.
Fontanil T; Mohamedi Y; Espina-Casado J; Obaya ÁJ; Cobo T; Cal S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804223
[TBL] [Abstract][Full Text] [Related]
12. Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex.
Mayer J; Hamel MG; Gottschall PE
BMC Neurosci; 2005 Aug; 6():52. PubMed ID: 16122387
[TBL] [Abstract][Full Text] [Related]
13. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
Viapiano MS; Hockfield S; Matthews RT
J Neurooncol; 2008 Jul; 88(3):261-72. PubMed ID: 18398576
[TBL] [Abstract][Full Text] [Related]
14. Neurocan: a brain chondroitin sulfate proteoglycan.
Rauch U; Feng K; Zhou XH
Cell Mol Life Sci; 2001 Nov; 58(12-13):1842-56. PubMed ID: 11766883
[TBL] [Abstract][Full Text] [Related]
15. Discordant localization of WFA reactivity and brevican/ADAMTS-derived fragment in rodent brain.
Ajmo JM; Eakin AK; Hamel MG; Gottschall PE
BMC Neurosci; 2008 Jan; 9():14. PubMed ID: 18221525
[TBL] [Abstract][Full Text] [Related]
16. Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats.
Yuan W; Matthews RT; Sandy JD; Gottschall PE
Neuroscience; 2002; 114(4):1091-101. PubMed ID: 12379262
[TBL] [Abstract][Full Text] [Related]
17. Chondroitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localization of neurocan and phosphacan.
Meyer-Puttlitz B; Junker E; Margolis RU; Margolis RK
J Comp Neurol; 1996 Feb; 366(1):44-54. PubMed ID: 8866845
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas.
Sim H; Hu B; Viapiano MS
J Biol Chem; 2009 Sep; 284(39):26547-56. PubMed ID: 19633295
[TBL] [Abstract][Full Text] [Related]
19. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue.
Tang X; Davies JE; Davies SJ
J Neurosci Res; 2003 Feb; 71(3):427-44. PubMed ID: 12526031
[TBL] [Abstract][Full Text] [Related]
20. Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone.
Beggah AT; Dours-Zimmermann MT; Barras FM; Brosius A; Zimmermann DR; Zurn AD
Neuroscience; 2005; 133(3):749-62. PubMed ID: 15896911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
